See also this year's filing and all EDGAR filings for this company.
PDF Report 0001389545_2023_NovaBay_Pharmaceuticals_Inc.pdf
Logs
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001389545, NovaBay Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,332,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,628,000 |
| 2 | PropertyPlantAndEquipmentNet | 119,000 |
| 3 | remainder_Assets | 2,320,000 |
| 4 | LiabilitiesCurrent | 4,257,000 |
| 5 | LiabilitiesNoncurrent | 1,588,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 6,623,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,489,000 |
| 9 | ResearchAndDevelopmentExpense | 174,000 |
| 10 | remainder_Expenses | 14,535,000 |
| 11 | remainder_Revenues | 14,404,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,399,000 |
| 1 | Liabilities | 5,845,000 |
| 2 | Expenses | 28,821,000 |
| 3 | Revenues | 14,404,000 |
| 4 | StockholdersEquity | 10,554,000 |
| 5 | NetIncome | -14,417,000 |
| 6 | ComprehensiveNetIncome | -14,417,000 |
| 7 | BaseVar | 32,734,500 |
| 8 | EconomicCapitalRatio | 0.336 |
Edgar->Model Mapping
Feature Distribution
Change over Time
